Cargando…
Prevalence of oral manifestations in children and adolescents with cancer submitted to chemotherapy
BACKGROUND: Oral complications may be observed during chemotherapy and are important side effects that may directly affect the anticancer treatment, even causing septicaemia in some cases. This research was done in order to evaluate changes in oral lesions during follow-up of children and adolescent...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5047274/ https://www.ncbi.nlm.nih.gov/pubmed/27716167 http://dx.doi.org/10.1186/s12903-016-0300-2 |
_version_ | 1782457392502407168 |
---|---|
author | Berger Velten, Deise Zandonade, Eliana Monteiro de Barros Miotto, Maria Helena |
author_facet | Berger Velten, Deise Zandonade, Eliana Monteiro de Barros Miotto, Maria Helena |
author_sort | Berger Velten, Deise |
collection | PubMed |
description | BACKGROUND: Oral complications may be observed during chemotherapy and are important side effects that may directly affect the anticancer treatment, even causing septicaemia in some cases. This research was done in order to evaluate changes in oral lesions during follow-up of children and adolescents in chemotherapy at Hospital Estadual Infantil Nossa Senhora da Glória (HEINSG). METHODS: The study design was longitudinal, 45 patients were evaluated and monitored for 1 month after the initiation of chemotherapy. Twenty-eight patients were male and 17 female, ranging from 3 months to 18 years old. RESULTS: The results show an increase in the number of mucositis cases and a decrease in xerostomia cases after the initiation of treatment, and other oral lesions were also found in low numbers. CONCLUSIONS: It is possible to avoid oral complications by maintaining a good oral health, and reducing infectious outbreaks. It is also feasible to obtain an early diagnosis of, and treat these oral complications, preventing them from following a more severe clinical course that may negatively affect the individual’s treatment. This outcome requires the presence of a dental surgeon on the multidisciplinary cancer treatment team. |
format | Online Article Text |
id | pubmed-5047274 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-50472742016-10-11 Prevalence of oral manifestations in children and adolescents with cancer submitted to chemotherapy Berger Velten, Deise Zandonade, Eliana Monteiro de Barros Miotto, Maria Helena BMC Oral Health Research Article BACKGROUND: Oral complications may be observed during chemotherapy and are important side effects that may directly affect the anticancer treatment, even causing septicaemia in some cases. This research was done in order to evaluate changes in oral lesions during follow-up of children and adolescents in chemotherapy at Hospital Estadual Infantil Nossa Senhora da Glória (HEINSG). METHODS: The study design was longitudinal, 45 patients were evaluated and monitored for 1 month after the initiation of chemotherapy. Twenty-eight patients were male and 17 female, ranging from 3 months to 18 years old. RESULTS: The results show an increase in the number of mucositis cases and a decrease in xerostomia cases after the initiation of treatment, and other oral lesions were also found in low numbers. CONCLUSIONS: It is possible to avoid oral complications by maintaining a good oral health, and reducing infectious outbreaks. It is also feasible to obtain an early diagnosis of, and treat these oral complications, preventing them from following a more severe clinical course that may negatively affect the individual’s treatment. This outcome requires the presence of a dental surgeon on the multidisciplinary cancer treatment team. BioMed Central 2016-10-03 /pmc/articles/PMC5047274/ /pubmed/27716167 http://dx.doi.org/10.1186/s12903-016-0300-2 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Berger Velten, Deise Zandonade, Eliana Monteiro de Barros Miotto, Maria Helena Prevalence of oral manifestations in children and adolescents with cancer submitted to chemotherapy |
title | Prevalence of oral manifestations in children and adolescents with cancer submitted to chemotherapy |
title_full | Prevalence of oral manifestations in children and adolescents with cancer submitted to chemotherapy |
title_fullStr | Prevalence of oral manifestations in children and adolescents with cancer submitted to chemotherapy |
title_full_unstemmed | Prevalence of oral manifestations in children and adolescents with cancer submitted to chemotherapy |
title_short | Prevalence of oral manifestations in children and adolescents with cancer submitted to chemotherapy |
title_sort | prevalence of oral manifestations in children and adolescents with cancer submitted to chemotherapy |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5047274/ https://www.ncbi.nlm.nih.gov/pubmed/27716167 http://dx.doi.org/10.1186/s12903-016-0300-2 |
work_keys_str_mv | AT bergerveltendeise prevalenceoforalmanifestationsinchildrenandadolescentswithcancersubmittedtochemotherapy AT zandonadeeliana prevalenceoforalmanifestationsinchildrenandadolescentswithcancersubmittedtochemotherapy AT monteirodebarrosmiottomariahelena prevalenceoforalmanifestationsinchildrenandadolescentswithcancersubmittedtochemotherapy |